These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4140987)

  • 1. Editorial: Oral bacterial vaccine and colds.
    Lancet; 1974 Dec; 2(7896):1552-3. PubMed ID: 4140987
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of a "mixed bacterial vaccine" in prophylaxis of acute respiratory infections: possible role of interferon.
    Rytel MW; Ferstenfeld JE; Rose HD; Balay J; Pierce WE; Lynch KL
    Am J Epidemiol; 1974 May; 99(5):347-59. PubMed ID: 4151096
    [No Abstract]   [Full Text] [Related]  

  • 3. [Assessment of salivary IgA titer in children with recurrent respiratory infections treated with polyvalent oral vaccine. A controlled study].
    Cimadamore N; Agriesti G; Testa A; Borgarello R; Capo G; Crua G
    Minerva Pediatr; 1988 Jun; 40(6):355-60. PubMed ID: 3054472
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyposensitization with bacterial vaccine in infectious asthma. A double-blind study and a longitudinal study.
    Mueller HL; Lanz M
    JAMA; 1969 May; 208(8):1379-83. PubMed ID: 4388775
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Oral bacterial vaccine and colds.
    Tyrrell DA
    Lancet; 1975 Jan; 1(7898):108. PubMed ID: 46001
    [No Abstract]   [Full Text] [Related]  

  • 6. Attempted induction of interferon by bacterial vaccines in allergic and nonallergic humans.
    Johnstone DE; Douglas RG; Simon R
    Ann Allergy; 1974 Feb; 32(2):70-2. PubMed ID: 4149323
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulin production in man stimulated by an orally administered bacterial lysate.
    Puigdollers JM; Serna GR; Hernandez del Rey I; Barruffet MT; Torroella JJ
    Respiration; 1980; 40(3):142-9. PubMed ID: 7003667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preventive immunoprevention of rhinitis and sinusitis. ENT director Dr. W. Elies, Bielefeld, elaborates on the indications].
    Elies W
    Fortschr Med; 1989 Sep; 107(26):70-1. PubMed ID: 2478431
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Oral bacterial vaccine and colds.
    Thomas G
    Lancet; 1975 Feb; 1(7903):400. PubMed ID: 46551
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bacterial polysaccharide vaccines: Meningococcus, Pneumococcus, Haemophilus influenzae].
    Triau R
    Rev Prat; 1984 Jun; 34(31):1683-90. PubMed ID: 6429835
    [No Abstract]   [Full Text] [Related]  

  • 12. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.
    Martin NG; Sadarangani M; Pollard AJ; Goldacre MJ
    Lancet Infect Dis; 2014 May; 14(5):397-405. PubMed ID: 24631222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New diagnostic and therapeutic options in bacterial meningitis in infants and children.
    Kim KS
    Minerva Pediatr; 2009 Oct; 61(5):531-48. PubMed ID: 19794379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The critically ill child: management of acute bacterial meningitis.
    Wehrle PF; Mathies AW; Leedom JM
    Pediatrics; 1969 Dec; 44(6):991-8. PubMed ID: 4391492
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of bacterial meningitis. Vaccines and chemoprophylaxis.
    Lieberman JM; Greenberg DP; Ward JI
    Infect Dis Clin North Am; 1990 Dec; 4(4):703-29. PubMed ID: 2126022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of in vitro activity of ten oral antimicrobial agents against respiratory tract pathogens.
    Platsouka E; Constantoulaki S; Dimitropoulos N; Niha M; Pierros N; Dimopoulou H; Paniara O
    J Chemother; 1995 Nov; 7 Suppl 4():58-60. PubMed ID: 8904108
    [No Abstract]   [Full Text] [Related]  

  • 17. [Peripheral blood cells secreting specific antibodies after oral stimulation with a ribosomal vaccine].
    Zanin C; Hauer S; Mole C; Bene MC; Faure GC
    Pathol Biol (Paris); 1992 May; 40(5):599-604. PubMed ID: 1495849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of an oral antigen in upper respiratory tract infections in two Bristol schools.
    Price HC; Henley G
    Practitioner; 1974 Nov; 213(1277):720-6. PubMed ID: 4617212
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-pyocyanic and anti-staphylococcal vaccinations in malignant hemopathies].
    Oberling F; Giron C; Bareiss MO; Lang JM; Reeb E; Goetz ML; Lavillaureix J
    Nouv Rev Fr Hematol; 1975; 15(3):386-90. PubMed ID: 128740
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of new bacterial vaccines in children.
    Klein JO
    Isr J Med Sci; 1983 Nov; 19(11):1026-9. PubMed ID: 6420367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.